Citations

Mayo Clinic

Showing 10 of 108572 citations.

Longitudinal default mode sub-networks in the language and visual variants of Alzheimer’s disease
Sintini, Irene , Corriveau‐Lecavalier, Nick , Jones, David T. , Gunter, Jeffrey L. , Schwarz, Christopher G. , Botha, Hugo , Carlos, Arenn F. , Kamykowski, Michael G. , Singh, Neha Atulkumar , Petersen, Ronald C. , Jack, Clifford R. , Lowe, Val J. , Graff‐Radford, Jonathan , Josephs, Keith A. , Whitwell, Jennifer L. , Schwarz, Christopher G , Botha, Hugo , Carlos, Arenn F , Singh, Neha Atulkumar , Jack, Clifford R , Graff-Radford, Jonathan , Josephs, Keith A , Whitwell, Jennifer , Jones, David T , Corriveau-Lecavalier, Nick , Machulda, Mary M.

Brain Communications | January 8, 2024 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcae005 | PMID 38444909 Get It

Abstract Disruption of the default mode network is a hallmark of Alzheimer’s disease, which has not been extensively examined in atypical phenotypes. We investigated cross-sectional and 1-year longitudinal changes in default mode network sub-systems in the visual and language variants of Alzheimer’s disease, in relation to age and tau. Sixty-one amyloid-positive Alzheimer’s disease participants diagnosed with posterior cortical atrophy (n = 33) or logopenic progressive aphasia (n = 28) underwent structural MRI, resting-state functional MRI and [18F]flortaucipir PET. One-hundred and twenty-two amyloid-negative cognitively unimpaired individuals and 60 amyloid-positive individuals diagnosed with amnestic Alzheimer’s disease were included as controls and as a comparison group, respectively, and had structural and resting-state functional MRI. Forty-one atypical Alzheimer’s disease participants, 26 amnestic Alzheimer’s disease participants and 40 cognitively unimpaired individuals had one follow-up functional MRI ∼1–2 years after the baseline scan. Default mode network connectivity was calculated using the dual regression method for posterior, ventral, anterior ventral and anterior dorsal sub-systems derived from independent component analysis. A global measure of default mode network connectivity, the network failure quotient, was also calculated. Linear mixed-effects models and voxel-based analyses were computed for each connectivity measure. Both atypical and amnestic Alzheimer’s disease participants had lower cross-sectional posterior and ventral and higher anterior dorsal connectivity and network failure quotient relative to cognitively unimpaired individuals. Age had opposite effects on connectivity in Alzheimer’s disease participants and cognitively unimpaired individuals. While connectivity declined with age in cognitively unimpaired individuals, younger Alzheimer’s disease participants had lower connectivity than the older ones, particularly in the ventral default mode network. Greater baseline tau-PET uptake was associated with lower ventral and anterior ventral default mode network connectivity in atypical Alzheimer’s disease. Connectivity in the ventral default mode network declined over time in atypical Alzheimer’s disease, particularly in older participants, with lower tau burden. Voxel-based analyses validated the findings of higher anterior dorsal default mode network connectivity, lower posterior and ventral default mode network connectivity and decline in ventral default mode network connectivity over time in atypical Alzheimer’s disease. Visuospatial symptoms were associated with default mode network connectivity disruption. In summary, default mode connectivity disruption was similar between atypical and amnestic Alzheimer’s disease variants, and discriminated Alzheimer’s disease from cognitively unimpaired individuals, with decreased posterior and increased anterior connectivity and with disruption more pronounced in younger participants. The ventral default mode network declined over time in atypical Alzheimer’s disease, suggesting a shift in default mode network connectivity likely related to tau pathology.
High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs
Luther, Vera , Schultz, Sara , Aziz, Mariam, Balba, Gayle , McCarty, Todd P , Reece, Rebecca , Shnekendorf, Rachel, Sundareshan, Vidya, Chirch, Lisa M , Abdoler, Emily , Acharya, Kartikey, Bartash, Rachel , Blyth, Dana M , Casańas, Beata, Chow, Brian , Clough, Lisa , Cutrell, James B , Doshi, Saumil, Sanctis, Jorgelina de, Faulhaber, Jason, Fiske, Christina T. , Graber, Christopher J. , Johnson, Leonard B., Kwon, Taesung, Lastinger, Allison , Lee, Mi-Kyung , Leuck, Anne‐Marie , Lichtenberger, Paola , Gil, Raul Macias , Mattar, Caline , Matt, Brionna, Maziarz, Eileen K , Melia, Michael T. , Lora, Alfredo J Mena , Miko, Benjamin A. , Mitra, Subhashis , Nematollahi, Saman , Osorio, Georgina, Perez, Frederico , Phadke, Varun K. , Prakash, Katya , Reid, Gail, Riedel, David J. , Rojas‐Moreno, Christian , Salas, Natalie Mariam , Schlaffer, Kathryn, Sobhanie, Mohammad Mahdee , Solomon, Daniel A. , Vikram, Holenarasipur R. , Weber, Devin , Wooten, Darcy , Zerbe, Christa S. , McCarty, T P , Luther, Vera P , Vikram, Holenarasipur R. , Paras, Molly L , Razonable, Raymund R. , Azar, Marwan M. , Blumberg, Emily A. , Butt, Saira , Dare, Ryan K , Dobrzynski, David , Hazra, Aniruddha , Kaltsas, Anna , Kulkarni, Prathit A. , Marcos, Luis A. , Okeke, Nwora Lance , Stapleton, Ann E. , Streit, Judy A. , Thompson, George R , Schooneveld, Trevor Van , Velagapudi, Manasa , Weisenberg, Scott A.

Open Forum Infectious Diseases | January 8, 2024 | Volume: 11 | Issue: 3 | Pages: No page available

10.1093/ofid/ofae016 | PMID 38434609 Get It

Abstract The Infectious Diseases Society of America Training Program Directors Committee met in October 2022 and discussed an observed increase in clinical volume and acuity on infectious diseases (ID) services, and its impact on fellow education. Committee members sought to develop specific goals and strategies related to improving training program culture, preserving quality education on inpatient consult services and in the clinic, and negotiating change at the annual IDWeek Training Program Director meeting. This paper outlines a presentation of ideas brought forth at the meeting and is meant to serve as a reference document for infectious diseases training program directors seeking guidance in this area.
Laparoscopic Median Arcuate Ligament Release: Surgical Technique and Clinical Outcomes
Belluzzi, Amanda, Salame, Marita , Kendrick, Michael L. , Ghanem, Omar M. , Abi Mosleh, Kamal , Mosleh, Kamal Abi , Rasmussen, Todd E.

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques | January 8, 2024 | Volume: 34 | Issue: 1 | Pages: 74-79

10.1097/sle.0000000000001257 | PMID 38190634 Get It

Background: Median arcuate ligament syndrome (MALS) is characterized by a constellation of symptoms related to the compression of the celiac artery trunk. Laparoscopic release of the ligament has demonstrated its effectiveness in alleviating these symptoms while showing lower postoperative complication rates, reduced hospital stays, and improved clinical outcomes. This study describes a single institution’s experience with this procedure and reports on the preoperative assessment, surgical technique, and clinical outcomes of patients with MALS. Methods: We performed a retrospective chart review of all patients who underwent a primary laparoscopic MAL release (MALR) at a single high-volume academic institution from June 2021 to July 2023. Patient demographics, preoperative assessment, postoperative complications, and resolution of preoperative symptoms data were collected. Results: A total of 30 patients underwent laparoscopic MALR, with 76.7% being female and a mean age of 33.4±16.3 years. The most common presenting symptom was postprandial epigastric pain (100%), followed by abdominal pain and nausea (83.3%), among others. The preoperative evaluation for all patients included a duplex mesenteric doppler and CT angiogram during inspiration and expiration and 3D reconstruction. Successful laparoscopic decompression of the celiac artery was achieved in 96.6% of cases, with only one conversion to an open procedure. There was only one reported early (<30 d postoperatively) complication with no subsequent late complications or mortality. None of the patients required reintervention or reoperation. Only 1 patient required postoperative celiac plexus/splanchnic block injection to alleviate pain. Conclusions: MALS can be effectively and safely managed using a laparoscopic approach when performed by an experienced minimally invasive surgeon. Further studies with longer follow-ups are needed to confirm the long-term effectiveness of this technique.
AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes
Pangrace, Michael , Dolan, Sheri, Grace, Thomas , Greene, Estay, Long, Eric C., McClelland, Scott, Moore, Josh, Morgan, Diane E., Mullins, Heather, Wescott, Susan, Long, Eric, McClelland, Scott

Journal of Managed Care & Specialty Pharmacy | January 8, 2024 | Volume: 30 | Issue: 1-a Suppl | Pages: S1-S15

10.18553/jmcp.2024.30.1-a.s1 | PMID 38190244 Get It

Neurologic Alternative Payment Models—Bridging the Gap
Kannarkat, Joseph T., Kannarkat, George T , Jones, Lyell K.

JAMA Neurology | January 8, 2024 | Volume: 81 | Issue: 4 | Pages: 311

10.1001/jamaneurol.2023.5053 | PMID 38190142 Get It

This Viewpoint discusses alternative payments models and the responsibilities of health care professionals.
Insulinoma: Metastatic Recurrence 38 Years Following Initial Diagnosis in Pregnancy
Preston, C. , Sachithanandan, Nirupa , Sim, Ie‐Wen, Heerden, Jon van, Preston, Christopher A , van Heerden, Jon, Farrell, Stephen

JCEM Case Reports | January 8, 2024 | Volume: 2 | Issue: 2 | Pages: No page available

10.1210/jcemcr/luad168 | PMID 38196815 Get It

Abstract A case of recurrent insulinoma spanning 4 decades is described. Following a delayed diagnosis, hyperinsulinemic hypoglycemia was confirmed in a 24-year-old woman during early pregnancy. Initial surgery, culminating in subtotal pancreatectomy, was noncurative. A 1-cm insulinoma was subsequently resected from the head of the pancreas postpartum, with postoperative resolution of hypoglycemia. However, 32 years later, the patient experienced a recurrence of hypoglycemic symptoms. Eventually, a subcentimeter extrapancreatic lesion was identified anterior to the pancreatic head on gallium-68 DOTA-Exendin-4 positron emission tomography/computed tomography. In 2022, a third operation was performed, with excision of a 4 × 3 mm tumor adjacent to the pancreatic head, and histology confirming insulinoma. She was again cured of symptoms.
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors
Pilbeam, Kristy , Pradhan, Kamnesh R. , Croop, James M. , Liu, Xiaowei , Voss, Stephan D. , Isikwei, Emasenyie , Fox, Elizabeth , Weigel, Brenda J. , Pilbeam, Kristy L , Voss, Stephan D , Minard, Charles G. , Berg, Stacey L. , Reid, Joel M.

Pediatric Blood & Cancer | January 8, 2024 | Volume: 71 | Issue: 3 | Pages: No page available

10.1002/pbc.30817 | PMID 38189770 Get It

AbstractBackgroundRamucirumab is a monoclonal antibody that binds the extracellular domain of vascular endothelial growth factor receptor (VEGFR‐2) and prevents binding of VEGF ligands. Based on population pharmacokinetic (PK) analysis and correlation with efficacy in adults, a target steady state trough concentration (Css,min) ≥ 50 µg/mL was established.ProceduresThis phase 1 trial (ADVL1416) used a rolling six design and a PK primary endpoint to define the recommended phase 2 dose (RP2D) of ramucirumab in children with recurrent/refractory solid tumors. Two dose levels (DL) were planned (DL1: 8 mg/kg, DL2: 12 mg/kg administered intravenously [IV] every 2 weeks). Toxicity during the initial 6 weeks was used to assess maximum tolerated dose (MTD). Cycle 1 Day 42 trough (Cmin) ≥ 50 µg/mL was the target concentration for the PK endpoint. At the RP2D, cohorts for PK expansion and children with central nervous tumors were planned.ResultsTwenty‐nine patients were enrolled; 28 were eligible; median age [range] = 13.5 [1–21] years; 22 were evaluable for the PK endpoint. Dose‐limiting proteinuria occurred at both DLs; however, the MTD was not exceeded. At DL2 (12 mg/kg), the median Day 42 Cmin (n = 16) was 87.8 µg/mL; 15 of 16 patients achieved a Cmin ≥ 50 µg/mL.ConclusionRamucirumab was well tolerated in children and adolescents with solid tumors. The RP2D for ramucirumab was 12 mg/kg IV every 2 weeks. This trial demonstrates the feasibility of incorporating a primary PK endpoint to determine dose escalation and the RP2D in children. Studies of ramucirumab in children with selected solid tumors are ongoing.
Development and validation of a scale to assess the belief that ‘age causes illness’
Stewart, Tara L., Schumann, Matthew E. , Ruthig, Joelle C.

Psychology & Health | January 8, 2024 | Volume: 40 | Issue: 7 | Pages: 1143-1155

10.1080/08870446.2023.2300037 | PMID 38189349 Get It

Prevalence and associations of multiple hypnotic prescriptions in a clinical sample
Chakravorty, Subhajit , Frank, Jacob A., Kolla, Bhanu Prakash , Mansukhani, Meghna P. , Coombes, Brandon J.

Journal of Clinical Sleep Medicine | January 8, 2024 | Volume: 20 | Issue: 5 | Pages: 793-800

10.5664/jcsm.10988 | PMID 38189358 Get It